Pilot trial: Pregabalin on colonic sensorimotor functions in irritable bowel syndrome

Digestive and Liver Disease

Volumn 46, Issue 2, 2014, Pages 113-118

  Iturrino, Johanna ^a,b   Camilleri, Michael ^a,b   Busciglio, Irene ^a,b   Burton, Duane ^a,b   Zinsmeister, Alan R ^c  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c Mayo Clinic College of Medicine   (United States)

Author keywords

Analgesia; Colonic compliance; Gas sensation; Pain sensation

Indexed keywords

PLACEBO; POLYETHYLENE; PREGABALIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLON DILATATION; COLON MOTILITY; CONSTIPATION; CONTROLLED STUDY; DIET RESTRICTION; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG ABSORPTION; DRUG INDUCED HEADACHE; FEMALE; HUMAN; IRRITABLE COLON; MALE; MIDDLE AGED; MOTOR PERFORMANCE; PARALLEL DESIGN; PILOT STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL; SENSATION; SENSORIMOTOR FUNCTION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANALGESIA; COLONIC COMPLIANCE; GAS SENSATION; PAIN SENSATION;

ADULT; ANALGESICS; COLON; COMPLIANCE; CONSTIPATION; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL MOTILITY; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; SENSATION; SENSORY THRESHOLDS; TREATMENT OUTCOME;

EID: 84893693732     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.09.002     Document Type: Article

References (30)

1. Locke G.R., Weaver A.L., Farmer S.A., et al. Functional gastrointestinal disorders among people with sleep disturbances: a population-based study. Mayo Clin Proc 2004, 79:1501-1506.
2. Dean B.B., Aguilar D., Barghout V., et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005, 11(1 Suppl):S17-S26.
3. Gralnek I.M., Hays R.D., Kilbourne A., et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000, 119:654-660.
4. Hungin A.P., Chang L., Locke G.R., et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005, 21:1365-1375.
5. Lovell R.M., Ford A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012, 10:712-721.
6. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 2012, 367:1626-1635.
7. Camilleri M., McKinzie S., Busciglio I., et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008, 6:772-781.
8. Grover M., Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol 2013, 48:177-181.
9. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther 2010, 31:35-46.
10. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004, 45(Suppl. 6):13-18.
11. Camilleri M. Alpha2delta ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome?. Gut 2007, 56:1337-1338.
12. Ravnefjord A., Brusberg M., Larsson H., et al. Effects of pregabalin on visceral pain responses and colonic compliance in rats. Br J Pharmacol 2008, 155:407-416.
13. Diop L., Raymond F., Fargeau H., et al. Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther 2002, 302:1013-1022.
14. Million M., Wang L., Adelson D.W., et al. Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut 2007, 56:1482-1484.
15. Houghton L.A., Fell C., Whorwell P.J., et al. Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome. Gut 2007, 56:1218-1225.
16. Iturrino J., Camilleri M., Busciglio I., et al. Effect of the A2δ ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Am J Physiol 2011, 301:G377-G384.
17. Talley N.J., Phillips S.F., Melton J., et al. A patient questionnaire to identify bowel disease. Ann Intern Med 1989, 111:671-674.
18. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370.
19. Ford M.J., Camilleri M., Wiste J.A., et al. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut 1995, 37:264-269.
20. Odunsi S.T., Camilleri M., Bharucha A.E., et al. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Digest Dis Sci 2010, 55:709-715.
21. Floyd B.N., Camilleri M., Andresen V., et al. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil 2008, 20:330-335.
22. von der Ohe M.R., Hanson R.B., Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut 1994, 35:536-541.
23. Bassotti G., Crowell M.D., Whitehead W.E. Contractile activity of the human colon: Lessons from 24-h studies. Gut 1993, 34:129-133.
24. Malcolm A., Camilleri M. Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol 2000, 95:715-719.
25. Bharucha A.E., Camilleri M., Zinsmeister A.R., et al. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997, 273:G997-G1006.
26. Delgado-Aros S., Chial H.J., Camilleri M., et al. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol 2003, 284:G558-G566.
27. Cremonini F., Mullan B.P., Camilleri M., et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther 2002, 16:1781-1790.
28. Camilleri M., Iturrino J., Bharucha A.E., et al. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil 2012, 24:1076-1562.
29. Cremonini F., Houghton L.A., Camilleri M., et al. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterol Motil 2005, 17:810-820.
30. Zaccara G., Gangemi P., Perucca P., et al. The adverse event profile of pregabalin: A systematic review and meta-analysis of randomized controlled trials. Epilepsia 2011, 52:826-836.